Martin B. Wax

Person

Wildwood, MO, US

People

Patents Grantslast 30 patents

Information Patent Grant
Ocular formulations for drug-delivery to the posterior segment of t...
- Patent number 10,307,404
- Issue date Jun 4, 2019
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery and protection of the anterio...
- Patent number 10,183,014
- Issue date Jan 22, 2019
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery to the posterior segment of t...
- Patent number 10,092,549
- Issue date Oct 9, 2018
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery and protection of the anterio...
- Patent number 9,814,702
- Issue date Nov 14, 2017
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of connexin 43 for treatment of IOP-relate...
- Patent number 9,752,147
- Issue date Sep 5, 2017
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery and protection of the anterio...
- Patent number 9,623,011
- Issue date Apr 18, 2017
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of connexin 43 for treatment of IOP-relate...
- Patent number 9,476,047
- Issue date Oct 25, 2016
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ocular formulations for drug-delivery to the posterior segment of t...
- Patent number 9,446,026
- Issue date Sep 20, 2016
- PanOptica, Inc.
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-related inhibition of TNF-alpha signaling pathway for treatmen...
- Patent number 9,422,556
- Issue date Aug 23, 2016
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi-mediated inhibition of connexin 43 for treatment of IOP-relate...
- Patent number 9,173,896
- Issue date Nov 3, 2015
- Arrowhead Research Corporation
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-related inhibition of TNF alpha signaling pathway for treatmen...
- Patent number 9,139,834
- Issue date Sep 22, 2015
- Arrowhead Research Corporation
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi-related inhibition of TNFα signaling pathway for treatment of...
- Patent number 8,865,670
- Issue date Oct 21, 2014
- Alcon Research, Ltd.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNAi-related inhibition of TNFα signaling pathway for treatment of...
- Patent number 8,754,202
- Issue date Jun 17, 2014
- Alcon Research, Ltd.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Water insoluble polymer matrix for drug delivery
- Patent number 8,632,809
- Issue date Jan 21, 2014
- Alcon Research, Ltd.
- Bahram Asgharian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of ocular targets
- Patent number 7,592,324
- Issue date Sep 22, 2009
- Alcon, Inc.
- Allan R. Shepard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating glaucoma
- Patent number 6,814,966
- Issue date Nov 9, 2004
- Pharmacia Corporation
- Martin B. Wax
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating glaucoma
- Patent number 6,531,128
- Issue date Mar 11, 2003
- Pharmacia Corporation
- Martin B. Wax
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20240325357
- Publication date Oct 3, 2024
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20240277674
- Publication date Aug 22, 2024
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20210275501
- Publication date Sep 9, 2021
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20210196690
- Publication date Jul 1, 2021
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20190314343
- Publication date Oct 17, 2019
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20190247368
- Publication date Aug 15, 2019
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20190240201
- Publication date Aug 8, 2019
- PanOptica, Inc.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20190183864
- Publication date Jun 20, 2019
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20180078531
- Publication date Mar 22, 2018
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATE...
- Publication number 20170009235
- Publication date Jan 12, 2017
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...
- Publication number 20160354349
- Publication date Dec 8, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...
- Publication number 20160326533
- Publication date Nov 10, 2016
- Arrowhead Pharmaceuticals, Inc.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...
- Publication number 20160206599
- Publication date Jul 21, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ocular Formulations for Drug-Delivery and Protection of the Anterio...
- Publication number 20160074371
- Publication date Mar 17, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ocular Formulations for Drug-Delivery to the Posterior Segment of t...
- Publication number 20160022646
- Publication date Jan 28, 2016
- PANOPTICA, INC.
- David P. BINGAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATE...
- Publication number 20160002638
- Publication date Jan 7, 2016
- ARROWHEAD RESEARCH CORPORATION
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...
- Publication number 20150344886
- Publication date Dec 3, 2015
- ARROWHEAD RESEARCH CORPORATION
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMEN...
- Publication number 20150057336
- Publication date Feb 26, 2015
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMEN...
- Publication number 20140357696
- Publication date Dec 4, 2014
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Ocular Formulations for Drug-Delivery to the Posterior Segment of t...
- Publication number 20140303219
- Publication date Oct 9, 2014
- David P. Bingaman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...
- Publication number 20110257248
- Publication date Oct 20, 2011
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF MULTI-PHARMACOPHORE COMPOUNDS TO TREAT NASAL DISORDERS
- Publication number 20110195962
- Publication date Aug 11, 2011
- ALCON RESEARCH, LTD.
- Najam A. Sharif
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...
- Publication number 20110190376
- Publication date Aug 4, 2011
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...
- Publication number 20110135579
- Publication date Jun 9, 2011
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...
- Publication number 20100267811
- Publication date Oct 21, 2010
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PERI-CORNEAL DRUG DELIVERY DEVICE
- Publication number 20100226962
- Publication date Sep 9, 2010
- Theron R. Rodstrom
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CON...
- Publication number 20100166676
- Publication date Jul 1, 2010
- ALCON RESEARCH, LTD.
- Allan R. Shepard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNAi-Mediated Inhibition of Ocular Targets
- Publication number 20090326044
- Publication date Dec 31, 2009
- ALCON RESEARCH, LTD.
- Allan R. Shepard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATE...
- Publication number 20090209627
- Publication date Aug 20, 2009
- ALCON RESEARCH, LTD.
- Jon E. Chatterton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma
- Publication number 20090117098
- Publication date May 7, 2009
- ALCON RESEARCH, LTD.
- Allan R. SHEPARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Martin B. Wax

Person

Patents Grantslast 30 patents

Ocular formulations for drug-delivery to the posterior segment of t...

Ocular formulations for drug-delivery and protection of the anterio...

Ocular formulations for drug-delivery to the posterior segment of t...

Ocular formulations for drug-delivery and protection of the anterio...

RNAi-mediated inhibition of connexin 43 for treatment of IOP-relate...

Ocular formulations for drug-delivery and protection of the anterio...

RNAi-mediated inhibition of connexin 43 for treatment of IOP-relate...

Ocular formulations for drug-delivery to the posterior segment of t...

RNAi-related inhibition of TNF-alpha signaling pathway for treatmen...

RNAi-mediated inhibition of connexin 43 for treatment of IOP-relate...

RNAi-related inhibition of TNF alpha signaling pathway for treatmen...

RNAi-related inhibition of TNFα signaling pathway for treatment of...

RNAi-related inhibition of TNFα signaling pathway for treatment of...

Water insoluble polymer matrix for drug delivery

RNAi-mediated inhibition of ocular targets

Methods for treating glaucoma

Methods for treating glaucoma

Patents Applicationslast 30 patents

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATE...

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF T...

RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...

OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIO...

Ocular Formulations for Drug-Delivery and Protection of the Anterio...

Ocular Formulations for Drug-Delivery to the Posterior Segment of t...

RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATE...

RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatmen...

RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMEN...

RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMEN...

Ocular Formulations for Drug-Delivery to the Posterior Segment of t...

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...

USE OF MULTI-PHARMACOPHORE COMPOUNDS TO TREAT NASAL DISORDERS

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF...

PERI-CORNEAL DRUG DELIVERY DEVICE

RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CON...

RNAi-Mediated Inhibition of Ocular Targets

RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATE...

Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma